Each week, Advanced Materials brings you a Review of a cutting-edge topic in materials science, accompanied by a number of short Communications. This issue, however, is different. For the first time, we have selected eight review articles written by leaders in their respective fields to survey what
Hepatitis C pharmacogenetics: State of the art in 2010
โ Scribed by Nezam H. Afdhal; John G. McHutchison; Stefan Zeuzem; Alessandra Mangia; Jean-Michel Pawlotsky; Jeffrey S. Murray; Kevin V. Shianna; Yasuhito Tanaka; David L. Thomas; David R. Booth; David B. Goldstein; for the Pharmacogenetics; Hepatitis C Meeting Participants
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 285 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
According to the third National Health and Nutrition Examination Survey (NHANES), 3.9 million of the U.S. civilian population have been infected with hepatitis C virus (HCV), of whom 2.7 million (74%) have chronic infection. Hepatitis C virus infection is most common among non-Caucasian men, ages 30
An imbalance between T helper cell (Th)1 and Th2-like cytokines has been described in several chronic infectious diseases. We therefore analyzed the intrahepatic messenger RNA (mRNA) expression of Th1-like (interleukin [IL]-2, interferon [IFN]-g) and Th2-like(IL-4, IL-10) cytokines in chronic hepati